Predictive and prognostic factors in patients with anaplastic lymphoma kinase rearranged early-stage lung adenocarcinoma

Clinical T1-2 N0 ALK-rearranged lung adenocarcinoma is an aggressive disease with a specific tropism for lymph nodes and the brain. High-grade tumours are predictive of nodal upstaging. Adjuvant treatment significantly improves DFS and overall survival in upstaged patients, highlighting the need for personalized preoperative staging and post-surgical management in this cohort.

Authors

Institutions

Publication Details

Journal
European Journal of Cardio-Thoracic Surgery
Published
2024-11-01
DOI
https://doi.org/10.1093/ejcts/ezae406
Citations
4
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
1.68
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Predictive and prognostic factors in patients with anaplastic lymphoma kinase rearranged early-stage lung adenocarcinoma

Federico Cappuzzo, Lorenzo Spaggiari, Filippo Tommaso Gallina, Lorenzo Ferri et al.
4 citations
European Journal of Cardio-Thoracic Surgery
Lung Cancer Treatments and Mutations
1.68
article

Predictive and prognostic factors in patients with anaplastic lymphoma kinase rearranged early-stage lung adenocarcinoma

Federico Cappuzzo, Lorenzo Spaggiari, Filippo Tommaso Gallina, Lorenzo Ferri, Alberto Giovanni Busetto, Isabella Sperduti, Francesca Mazzoni, Enrico Melis, Nicola Martucci, Luca Bertolaccini, Luca Voltolini, Federico Rea, Fabiana Letizia Cecere, Jonathan Spicer, Edoardo Mercadante, Giorgio Cannone, Riccardo Tajè, Stefano Bongiolatti, Monica Casiraghi, Francesco Facciolo, Roni Rayes, Giuseppe De Luca
article en
4 citations

Abstract

Clinical T1-2 N0 ALK-rearranged lung adenocarcinoma is an aggressive disease with a specific tropism for lymph nodes and the brain. High-grade tumours are predictive of nodal upstaging. Adjuvant treatment significantly improves DFS and overall survival in upstaged patients, highlighting the need for personalized preoperative staging and post-surgical management in this cohort.

European Journal of Cardio-Thoracic SurgeryVol. 66(5)
University of Padua (IT), University of Milan (IT), McGill University Health Centre (CA), Azienda Ospedaliero-Universitaria Careggi (IT), National Cancer Institute (MY), Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), European Institute of Oncology (IT)
Good health and well-being
Openalex Percentile: Top 14%
Lung Cancer Treatments and Mutations
1.68
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.